MedTrace Logo

NHF in Acute Hypercapnic Acute Exacerbation of COPD

NCT03523481 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 38

Last updated 2018-06-25

No results posted yet for this study

Summary

Patients with AECOPD and NIV failure and in absence will be treated with NHF device. Inclusion criteria are pH \< 7,38 and pCO2 \> 45 mm Hg. Patients were treated if pH \>7,38 or refusal of therapy.

Conditions

  • Safety of NHF in Acute Hypercapnic AECOPD

Sponsors & Collaborators

  • Jens Bräunlich, MD

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-05-15
Primary Completion
2018-05-30
Completion
2018-05-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03523481 on ClinicalTrials.gov